Novo Nordisk Breach Highlights Software Development Pipeline Risk
(darkreading.com)
1.
2.
Novo Nordisk Breach Exposes Software Development Pipeline Risk
(darkreading.com)
3.
Leak confirms OpenAI is testing a ChatGPT for Science subscription
(bleepingcomputer.com)
5.
Pharma giant Novo Nordisk discloses breach of clinical trials data
(bleepingcomputer.com)
6.
7.
Is the weight-loss drug boom moving past the Ozempic era?
(feeds.feedburner.com)
8.
The biggest shift in the weight-loss drug boom may not be Ozempic anymore
(feeds.feedburner.com)
9.
How to secure philanthropic funding in a competitive climate
(feeds.nature.com)
11.
Wegovy Maker Novo Nordisk Strikes Deal With OpenAI to Speed Up Drug Discovery
(feeds.content.dowjones.io)
12.
Novo Nordisk and OpenAI Partner to Speed Drug Discovery
(feeds.content.dowjones.io)
15.
A new weight-loss pill is here, and it could reshape the GLP-1 market
(feeds.feedburner.com)
16.
FDA Approves Eli Lilly's GLP-1 Pill
(wired.com)
17.
Wegovy’s new pricing could save you $1,200—but it’s not for everyone
(feeds.feedburner.com)
18.
Ro CEO on the next phase of the Ozempic boom
(feeds.feedburner.com)
19.
20.
Can weight-loss pills replace injectables? What the science says
(feeds.nature.com)
22.
Ozempic just released its own version of the iconic Mac vs. PC ad
(feeds.feedburner.com)
25.
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
(news.ycombinator.com)
26.
FDA Approves Pill Version of Wegovy
(wired.com)
27.